N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: A randomized trial

Clinical Nephrology

Volumn 74, Issue 4, 2010, Pages 323-326

  Burns, K E A ^a,b   Priestap, F ^c,d   Martin, C ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE;

ADULT; ANAPHYLAXIS; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DRUG EFFECT; DRUG MEGADOSE; HUMAN; HYDRATION; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LENGTH OF STAY; LETTER; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 77957653068     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74323     Document Type: Letter

References (2)

1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHEII: a severity of disease classification system. Crit Care Med. 1985; 13: 818-829. (Pubitemid 15250137)
2. LeGall JR, Klar J, Lemeshow S et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996; 276: 802-810.